Atyr Pharma Inc (NASDAQ:ATYR) has a beta value of 0.90 and has seen 1.1 million shares traded in the recent trading session. The company, currently valued at $455.70M, closed the recent trade at $5.12 per share which meant it lost -$0.19 on the day or -3.58% during that session. The ATYR stock price is -16.8% off its 52-week high price of $5.98 and 71.48% above the 52-week low of $1.46. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.52 million shares traded. The 3-month trading volume is 1.77 million shares.
Atyr Pharma Inc (NASDAQ:ATYR) trade information
Sporting -3.58% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the ATYR stock price touched $5.12 or saw a rise of 6.74%. Year-to-date, Atyr Pharma Inc shares have moved 243.62%, while the 5-day performance has seen it change -0.39%. Over the past 30 days, the shares of Atyr Pharma Inc (NASDAQ:ATYR) have changed 36.53%. Short interest in the company has seen 13.77 million shares shorted with days to cover at 9.72.
Atyr Pharma Inc (ATYR) estimates and forecasts
The company’s shares have gained 62.54% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 34.28% over the past 5 years.
ATYR Dividends
Atyr Pharma Inc is expected to release its next earnings report on 2025-May-07 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Atyr Pharma Inc (NASDAQ:ATYR)’s Major holders
Insiders own 2.23% of the company shares, while shares held by institutions stand at 69.63% with a share float percentage of 71.22%. Investors are also buoyed by the number of investors in a company, with Atyr Pharma Inc having a total of 103.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Federated Hermes Equity Funds-Federated Hermes Kaufmann Fund and Federated Hermes Equity Funds-Federated Hermes Kaufmann Small Cap Fund . As of Jan 31, 2025 , the former fund manager holds about 8.82% shares in the company for having 7.85 shares of worth $40.03 million while later fund manager owns 6.62 shares of worth $33.76 million as of Jan 31, 2025 , which makes it owner of about 7.44% of company’s outstanding stock.
